Why the study?
Does electrophysiological stimulation predict arrhythmia recurrence or survival in patients with idiopathic dilated cardiomyopathy and symptomatic ventricular tachyarrhythmias?
Does electrophysiological stimulation predict arrhythmia recurrence or survival in patients with idiopathic dilated cardiomyopathy and symptomatic ventricular tachyarrhythmias?
In patients with idiopathic dilated cardiomyopathy, non-inducibility during EPS or prevention of induction with antiarrhythmic therapy does not confer long-term protection against recurrent arrhythmias.
Answers are grounded in this paper and cite their sources.
EPS non-inducibility should not guide therapy in idiopathic dilated cardiomyopathy; leaves open its value for arrhythmia risk stratification.
Sustained ventricular tachyarrhythmias and sudden death are particularly prevalent in patients with idiopathic dilated cardiomyopathy (IDC). In contrast to patients with ischemic heart disease, the value 0/electrophysiological stimulation (EPSJ in patients with IDC has not yet been established. To clarify the role of EPS in these patients, we studied 19 patients (58 ± 11 years) with IDC who had symptomatic ventricular tachycardia (VT) or ventricular fibrillation (VF). The mean left ventricular ejection fraction was 26 ± 9%. Ten patients had survived out‐of‐hospital cardiac arrest, eight had documented sustained monomorphic VT and one patient had non‐sustained VT associated with syncope. Thirteen of the 19 patients (68%) had their clinical ventricular tachyarrhythmias induced at EPS (12 VT, 1 VF). In nine of 13 patients (69%), the arrhythmias were subsequently suppressed during serial electrophysiological drug testing. During 17 ± 11 months of follow‐up, 10/19 (53%) patients experienced recurrence of their arrhythmias and nine out of 19 (47%) patients died; six died suddenly and three secondary to heart failure. There was no difference in arrhythmia recurrence between patients with and without inducible ventricular tachyarrhythmias at initial study. Furthermore, suppression of arrhythmia during serial testing did not predict outcome; recurrences were observed in jive out of nine patients whose arrhythmias were suppressed. These data indicate that the sensitivity of programmed ventricular stimulation in patients with IDC and symptomatic ventricular tachyarrhythmias is approximately 70%, and that non‐inducibility during control EPS or prevention of arrhythmia induction with antiarrhythmic therapy does not confer long‐term protection against recurrent arrhythmias.
No takes yet. Share an insight, caveat, or question.
Milner et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: